companydata.dkNovo Nordisk Invest 4 A/S: Financial statements 2021
CVR: 31853923
Novo Nordisk Invest 4 A/S (CVR 31853923) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK -37,000 compared with DKK -108,000 the year before. Equity amounted to DKK 1,779,000. The solvency ratio was 79.8%.
- Profit/Loss
- -37,000 kr.
- Equity
- 1,779,000 kr.
- Total Assets
- 2,229,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | - | -37 t. | 1.8 mio. | - |
| 2020 | - | - | -108 t. | 1.8 mio. | - |
| 2019 | - | - | -398 t. | 8.9 mio. | - |
| 2018 | - | - | 189 t. | 9.3 mio. | - |
| 2017 | - | - | -775 t. | 9.1 mio. | - |
Find more companies like Novo Nordisk Invest 4 A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Novo Nordisk Invest 4 A/S has published its annual report for 2020. The net result was DKK -108,000.
As of May 12, 2021, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Novo Nordisk Invest 4 A/S.
As of May 12, 2021, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Novo Nordisk Invest 4 A/S.
About Novo Nordisk Invest 4 A/S
Novo Nordisk Invest 4 A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2008. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named STENO DIABETES CENTER A/S. The management consists of Anders Rytter Mikkelsen. The company is owned by NOVO NORDISK A/S. The company has 0 employees. In 2025, the company reported a gross profit of DKK -64,000 and a net result of DKK -23,000 compared with DKK 7,000 the year before. Equity amounted to DKK 1,772,000.